MONTELUKAST SODIUM (MONTELUKAST SODIUM) — FDA Approval ANDA202096 (AUROBINDO PHARMA LTD)
MONTELUKAST SODIUM (MONTELUKAST SODIUM) — FDA Approval ANDA202096 (AUROBINDO PHARMA LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: MONTELUKAST SODIUM; Active ingredients: MONTELUKAST SODIUM; Application number: ANDA202096.
| Brand name | MONTELUKAST SODIUM |
|---|---|
| Active ingredients | MONTELUKAST SODIUM |
| Application number | ANDA202096 |
| Sponsor | AUROBINDO PHARMA LTD |
| Dosage form | TABLET, CHEWABLE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20120803 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →